Current status and surgical advances in adult heart transplantation in the United States_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

 LIANG Hongliang

Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California, 94305, USA;

Corresponding author：

LIANG Hongliang, Email: lianghl@stanford.edu

Keywords：

Heart transplantation; donation after brain death; donation after circulatory death; extended criteria donors; multi-organ transplantation; primary graft dysfunction; mechanical circulatory support; artificial intelligence; review

DOI：

10.7507/1007-4848.202406032

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Heart transplantation remains the most effective treatment for patients with end-stage heart failure. Over the past decade, significant advancements have been made in the field of heart transplant surgery. However, the enormous demand from heart failure patients and the severe shortage of available donor hearts continue to be major obstacles to the widespread application of heart transplantation. With the development of donor heart recovery, preservation, and evaluation techniques, the use of extended criteria donors and donation after circulatory death has increased. These technological advancements have expanded the safe ischemic time and geographic range for donor heart procurement, significantly enlarging the donor pool and driving a rapid increase in heart transplant cases. Concurrently, many new techniques have emerged in heart transplant surgery and perioperative management, particularly the rapid advancements in mechanical circulatory support and artificial intelligence, which hold the potential to revolutionize the field. This article reviews and discusses the current status and major surgical advancements in adult heart transplantation in the United States, aiming to provide insights and stimulate ongoing exploration and innovation in this field.

Citation： LIANG Hongliang. Current status and surgical advances in adult heart transplantation in the United States. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(11): 1567-1588. doi: 10.7507/1007-4848.202406032 Copy

1.	Martin SS, Aday AW, Almarzooq ZI, et al. 2024 Heart Disease and Stroke Statistics: A report of US and Global Data from the American Heart Association. Circulation, 2024, 149(8): e347-e913.
2.	Barnard CN. The operation. A human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J, 1967, 41(48): 1271-1274.
3.	Zhu Y, Lingala B, Baiocchi M, et al. The Stanford experience of heart transplantation over five decades. Eur Heart J, 2021, 42(48): 4934-4943.
4.	Khush KK, Hsich E, Potena L, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report-2021; Focus on recipient characteristics. J Heart Lung Transplant, 2021, 40(10): 1035-1049.
5.	Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report-2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant, 2019, 38(10): 1056-1066.
6.	Colvin MM, Smith JM, Ahn YS, et al. OPTN/SRTR 2022 Annual Data Report: Heart. Am J Transplant, 2024, 24(2S1): S305-S393.
7.	Jaiswal A, Gadela NV, Baran D, et al. Clinical outcomes of older adults listed for heart transplantation in the United States. J Am Geriatr Soc, 2021, 69(9): 2507-2517.
8.	Wever-Pinzon O, Edwards LB, Taylor DO, et al. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management: An analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant, 2017, 36(4): 407-417.
9.	Awad MA, Shah A, Griffith BP. Current status and outcomes in heart transplantation: A narrative review. Rev Cardiovasc Med, 2022, 23(1): 11.
10.	Schroder JN, Scheuer S, Catarino P, et al. The American Association for Thoracic Surgery 2023 Expert Consensus Document: Adult cardiac transplantation utilizing donors after circulatory death. J Thorac Cardiovasc Surg, 2023, 166(3): 856-869.
11.	Chew HC, Iyer A, Connellan M, et al. Outcomes of donation after circulatory death heart transplantation in Australia. J Am Coll Cardiol, 2019, 73(12): 1447-1459.
12.	Schroder JN, Patel CB, DeVore AD, et al. Transplantation outcomes with donor hearts after circulatory death. N Engl J Med, 2023, 388(23): 2121-2131.
13.	Chen Q, Emerson D, Megna D, et al. Heart transplantation using donation after circulatory death in the United States. J Thorac Cardiovasc Surg, 2023, 165(5): 1849-1860.
14.	Urban M, Moody M, Lyden E, et al. Impact of donation after circulatory death heart transplantation on waitlist outcomes and transplantation activity. Clin Transplant, 2023, 37(5): e14942.
15.	Smith DE, Kon ZN, Carillo JA, et al. Early experience with donation after circulatory death heart transplantation using normothermic regional perfusion in the United States. J Thorac Cardiovasc Surg, 2022, 164(2): 557-568.
16.	Madan S, Saeed O, Forest SJ, et al. Feasibility and potential impact of heart transplantation from adult donors after circulatory death. J Am Coll Cardiol, 2022, 79(2): 148-162.
17.	Gernhofer YK, Bui QM, Powell JJ, et al. Heart transplantation from donation after circulatory death: Impact on waitlist time and transplant rate. Am J Transplant, 2023, 23(8): 1241-1255.
18.	Hornby L, Dhanani S, Shemie SD. Update of a systematic review of autoresuscitation after cardiac arrest. Crit Care Med, 2018, 46(3): e268-e272.
19.	Croome KP, Barbas AS, Whitson B, et al. American Society of Transplant Surgeons recommendations on best practices in donation after circulatory death organ procurement. Am J Transplant, 2023, 23(2): 171-179.
20.	Joshi Y, Villanueva J, Gao L, et al. Donation after circulatory death: A new frontier. Curr Cardiol Rep, 2022, 24(12): 1973-1981.
21.	Shudo Y, Benjamin-Addy R, Koyano TK, et al. Donors after circulatory death heart trial. Future Cardiol, 2021, 17(1): 11-17.
22.	Lerman JB, Agarwal R, Patel CB, et al. Donor heart recovery and preservation modalities in 2024. JACC Heart Fail, 2024, 12(3): 427-437.
23.	White CW, Ambrose E, Müller A, et al. Assessment of donor heart viability during ex vivo heart perfusion. Can J Physiol Pharmacol, 2015, 93(10): 893-901.
24.	Fedson S. Heart transplant donation after circulatory death: Current status and implications. Curr Opin Cardiol, 2024, 39(2): 128-134.
25.	Langmuur SJJ, Amesz JH, Veen KM, et al. Normothermic ex situ heart perfusion with the organ care system for cardiac transplantation: A meta-analysis. Transplantation, 2022, 106(9): 1745-1753.
26.	Schroder JN, Patel CB, DeVore AD, et al. Increasing utilization of extended criteria donor hearts for transplantation: The OCS Heart EXPAND Trial. JACC Heart Fail, 2024, 12(3): 438-447.
27.	Kothari P. Ex-vivo preservation of heart allografts: An overview of the current state. J Cardiovasc Dev Dis, 2023, 10(3): 105.
28.	Urban M, Ryan TR, Um JY, et al. Financial impact of donation after circulatory death heart transplantation: A single-center analysis. Clin Transplant, 2024, 38(4): e15296.
29.	Kounatidis D, Brozou V, Anagnostopoulos D, et al. Donor heart preservation: Current knowledge and the new era of machine perfusion. Int J Mol Sci, 2023, 24(23): 16693.
30.	Joyce DL, Carlson SF, Kohmoto T, et al. Thoracoabdominal normothermic regional perfusion for cardiac procurement. ASAIO J, 2022, 68(10): e163-e165.
31.	Alamouti-Fard E, Garg P, Wadiwala IJ, et al. Normothermic regional perfusion is an emerging cost-effective alternative in donation after circulatory death (DCD) in heart transplantation. Cureus, 2022, 14(6): e26437.
32.	Hoffman JRH, McMaster WG, Rali AS, et al. Early US experience with cardiac donation after circulatory death (DCD) using normothermic regional perfusion. J Heart Lung Transplant, 2021, 40(11): 1408-1418.
33.	Messer S, Cernic S, Page A, et al. A 5-year single-center early experience of heart transplantation from donation after circulatory-determined death donors. J Heart Lung Transplant, 2020, 39(12): 1463-1475.
34.	Entwistle JW, Drake DH, Fenton KN, et al. Normothermic regional perfusion: Ethical issues in thoracic organ donation. Ann Thorac Surg, 2022, 114(1): 44-51.
35.	D'Alessandro D, Schroder J, Meyer DM, et al. Impact of controlled hypothermic preservation on outcomes following heart transplantation. J Heart Lung Transplant, 2024, 43(7): 1153-1161.
36.	Hendry PJ, Walley VM, Koshal A, et al. Are temperatures attained by donor hearts during transport too cold? J Thorac Cardiovasc Surg, 1989, 98(4): 517-522.
37.	Michel SG, LaMuraglia Ii GM, Madariaga ML, et al. Innovative cold storage of donor organs using the Paragonix Sherpa Pak devices. Heart Lung Vessel, 2015, 7(3): 246-255.
38.	Copeland H, Hayanga JWA, Neyrinck A, et al. Donor heart and lung procurement: A consensus statement. J Heart Lung Transplant, 2020, 39(6): 501-517.
39.	Radakovic D, Karimli S, Penov K, et al. First clinical experience with the novel cold storage SherpaPak™ system for donor heart transportation. J Thorac Dis, 2020, 12(12): 7227-7235.
40.	Bitargil M, Haddad O, Pham SM, et al. Packing the donor heart: Is SherpaPak cold preservation technique safer compared to ice cold storage. Clin Transplant, 2022, 36(8): e14707.
41.	Zhu Y, Shudo Y, He H, et al. Outcomes of heart transplantation using a temperature-controlled hypothermic storage system. Transplantation, 2023, 107(5): 1151-1157.
42.	Shudo Y, Leacche M, Copeland H, et al. A paradigm shift in heart preservation: Improved post-transplant outcomes in recipients of donor hearts preserved with the SherpaPak System. ASAIO J, 2023, 69(11): 993-1000.
43.	Voigt JD, Leacche M, Copeland H, et al. Multicenter registry using propensity score analysis to compare a novel transport/preservation system to traditional means on postoperative hospital outcomes and costs for heart transplant patients. ASAIO J, 2023, 69(4): 345-349.
44.	Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation, 1988, 45(4): 673-676.
45.	McGiffin DC, Kure CE, Macdonald PS, et al. Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trial. J Heart Lung Transplant, 2024, 43(3): 485-495.
46.	Steen S, Paskevicius A, Liao Q, et al. Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours. Scand Cardiovasc J, 2016, 50(3): 193-200.
47.	Nilsson J, Jernryd V, Qin G, et al. A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation. Nat Commun, 2020, 11(1): 2976.
48.	Critsinelis AC, Patel S, Nordan T, et al. Trends in outcomes of heart transplants using extended criteria donors: A United Network for Organ Sharing database analysis. Ann Thorac Surg, 2023, 115(6): 1503-1509.
49.	Felker GM, Milano CA, Yager JE, et al. Outcomes with an alternate list strategy for heart transplantation. J Heart Lung Transplant, 2005, 24(11): 1781-1786.
50.	Weber DJ, Wang IW, Gracon AS, et al. Impact of donor age on survival after heart transplantation: An analysis of the United Network for Organ Sharing (UNOS) registry. J Card Surg, 2014, 29(5): 723-728.
51.	Shudo Y, Guenther SP, Lingala B, et al. Relation of length of survival after orthotopic heart transplantation to age of the donor. Am J Cardiol, 2020, 131: 54-59.
52.	Lechiancole A, Vendramin I, Sponga S, et al. Influence of donor-transmitted coronary artery disease on long-term outcomes after heart transplantation: A retrospective study. Transpl Int, 2021, 34(2): 281-289.
53.	Jahanyar J, Liao JM, Zhang N, et al. Does pre-existing donor heart coronary artery disease impact survival after orthotopic heart transplantation? J Heart Lung Transplant, 2019, 38(4): S185-S186.
54.	Sibona A, Khush KK, Oyoyo UE, et al. Long-term transplant outcomes of donor hearts with left ventricular dysfunction. J Thorac Cardiovasc Surg, 2019, 157(5): 1865-1875.
55.	Chen CW, Sprys MH, Gaffey AC, et al. Low ejection fraction in donor hearts is not directly associated with increased recipient mortality. J Heart Lung Transplant, 2017, 36(6): 611-615.
56.	Wever Pinzon O, Stoddard G, Drakos SG, et al. Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant, 2011, 11(12): 2755-2761.
57.	McCulloch MA, Zuckerman WA, Möller T, et al. Effects of donor cause of death, ischemia time, inotrope exposure, troponin values, cardiopulmonary resuscitation, electrocardiographic and echocardiographic data on recipient outcomes: A review of the literature. Pediatr Transplant, 2020, 24(3): e13676.
58.	Quader MA, Wolfe LG, Kasirajan V. Heart transplantation outcomes from cardiac arrest-resuscitated donors. J Heart Lung Transplant, 2013, 32(11): 1090-1095.
59.	Galeone A, Varnous S, Lebreton G, et al. Impact of cardiac arrest resuscitated donors on heart transplant recipients' outcome. J Thorac Cardiovasc Surg, 2017, 153(3): 622-630.
60.	Kulshrestha K, Greenberg JW, Guzman-Gomez AM, et al. Up to an hour of donor resuscitation does not affect pediatric heart transplantation survival. Ann Thorac Surg, 2024, 117(3): 611-618.
61.	Leon M, Shudo Y. Optimizing donor heart utilization amidst organ shortage: Feasibility of using hearts post-long CPR. Ann Thorac Surg, 2024, 13: S0003-4975.
62.	Copeland H, Knezevic I, Baran DA, et al. Donor heart selection: Evidence-based guidelines for providers. J Heart Lung Transplant, 2023, 42(1): 7-29.
63.	Gaffey AC, Doll SL, Thomasson AM, et al. Transplantation of "high-risk" donor hearts: Implications for infection. J Thorac Cardiovasc Surg, 2016, 152(1): 213-220.
64.	Gaffey AC, Cucchiara AJ, Goldberg LR, et al. Transplantation of center for disease control "high-risk" donor hearts does not adversely impact long-term outcomes in adults. J Card Fail, 2016, 22(5): 376-382.
65.	Gasink LB, Blumberg EA, Localio AR, et al. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients. JAMA, 2006, 296(15): 1843-1850.
66.	Aslam S, Grossi P, Schlendorf KH, et al. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. J Heart Lung Transplant, 2020, 39(5): 418-432.
67.	Huckaby LV, Seese LM, Handzel R, et al. Center-level utilization of hepatitis C virus-positive donors for orthotopic heart transplantation. Transplantation, 2021, 105(12): 2639-2645.
68.	Wang JH, Gustafson SK, Skeans MA, et al. OPTN/SRTR 2018 annual data report: Hepatitis C. Am J Transplant, 2020, 20 Suppl s1: 542-568.
69.	Gernhofer YK, Brambatti M, Greenberg BH, et al. The impact of using hepatitis C virus nucleic acid test-positive donor hearts on heart transplant waitlist time and transplant rate. J Heart Lung Transplant, 2019, 38(11): 1178-1188.
70.	Mohiuddin MM, Singh AK, Scobie L, et al. Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: A case report. Lancet, 2023, 402(10399): 397-410.
71.	Peterson L, Yacoub MH, Ayares D, et al. Physiological basis for xenotransplantation from genetically modified pigs to humans. Physiol Rev, 2024, 104(3): 1409-1459.
72.	Schmauch E, Piening B, Mohebnasab M, et al. Integrative multi-omics profiling in human decedents receiving pig heart xenografts. Nat Med, 2024, 30(5): 1448-1460.
73.	Krishnan A, Kasinpila P, Wang H, et al. First-in-human beating-heart transplant. JTCVS Tech, 2023, 19: 80-85.
74.	Krishnan A, Guenthart BA, Ruaengsri C, et al. Beating heart transplantation: How to do it. Innovations (Phila), 2024, 19(1): 88-91.
75.	Krishnan A, Ruaengsri C, Guenthart BA, et al. Beating heart transplant procedures using organs from donors with circulatory death. JAMA Netw Open, 2024, 7(3): e241828.
76.	Kothari P, Kiwakyou LM, Guenthart BA, et al. Beating heart transplants-overview and implications for anesthesiologists. J Cardiothorac Vasc Anesth, 2024, 38(3): 610-615.
77.	Rajab TK. Partial heart transplantation: Growing heart valve implants for children. Artif Organs, 2024, 48(4): 326-335.
78.	Overbey DM, Rajab TK, Turek JW. Partial heart transplantation: How to change the system. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 2024, 27: 100-105.
79.	Halder V, Mishra A, Ghosh S, et al. Effectiveness and safety of the Ozaki procedure for aortic valve disease in pediatric patients: A systematic review and meta-analysis. Cureus, 2023, 15(9): e45269.
80.	Rajab TK, Vogel AD, Alexander VS, et al. The future of partial heart transplantation. J Heart Lung Transplant, 2024, 43(6): 863-865.
81.	Sherard C, Bisbee C, Konsek H, et al. Partial heart transplantation in adult cardiac surgery. Innovations (Phila), 2023, 18(2): 126-131.
82.	McGiffin DC, Kirklin JK. The impact of aortic valve homografts on the treatment of aortic prosthetic valve endocarditis. Semin Thorac Cardiovasc Surg. 1995, 7(1): 25-31.
83.	Hill MA, Kwon JH, Gerry B, et al. Immune privilege of heart valves. Front Immunol, 2021, 12: 731361.
84.	Kwon JH, Hill MA, Gerry B, et al. Cellular viability of partial heart transplant grafts in cold storage. Front Surg, 2021, 8: 676739.
85.	Reitz BA. The first successful combined heart-lung transplantation. J Thorac Cardiovasc Surg, 2011, 141(4): 867-869.
86.	Shudo Y, Wang H, Lingala B, et al. Evaluation of risk factors for heart-lung transplant recipient outcome: An analysis of the United Network for Organ Sharing database. Circulation, 2019, 140(15): 1261-1272.
87.	Elde S, Baccouche BM, Mullis DM, et al. Four decades of progress in heart-lung transplantation: Two hundred seventy-one cases at a single institution. J Thorac Cardiovasc Surg, 2024. [Epub ahead of print].
88.	Beal EW, Mumtaz K, Hayes D, et al. Combined heart-liver transplantation: Indications, outcomes and current experience. Transplant Rev (Orlando), 2016, 30(4): 261-268.
89.	Emamaullee J, Zaidi AN, Schiano T, et al. Fontan-associated liver disease: Screening, management, and transplant considerations. Circulation, 2020, 142(6): 591-604.
90.	Shaw BW, Bahnson HT, Hardesty RL, et al. Combined transplantation of the heart and liver. Ann Surg, 1985, 202(6): 667-672.
91.	Lee JTC, Sarode D, Emamaullee JA. Review of pediatric combined heart-liver transplantation: A roadmap to success. Pediatr Transplant, 2023, 27(8): e14633.
92.	Elde S, Brubaker AL, Than PA, et al. Operative technique of donor organ procurement for en bloc heart-liver transplantation. Transplantation, 2021, 105(12): 2661-2665.
93.	Brozzi NA, Loebe M, Souki FG, et al. En-bloc simultaneous heart-liver transplantation in adult patients. Ann Surg, 2021, 274(6): e1284-e1289.
94.	Kobashigawa J, VanWagner LB, Hall S, et al. Summary of a consensus conference on heart-liver transplantation. Am J Transplant, 2024, 24(3): 380-390.
95.	Kittleson MM, Sharma K, Brennan DC, et al. Dual-organ transplantation: Indications, evaluation, and outcomes for heart-kidney and heart-liver transplantation: A scientific statement from the American Heart Association. Circulation, 2023, 148(7): 622-636.
96.	Rizvi SSA, Challapalli J, Maynes EJ, et al. Indications and outcomes of combined heart-liver transplant: A systematic review and met-analysis. Transplant Rev (Orlando), 2020, 34(2): 100517.
97.	Brocklebank P, Shorbaji K, Welch BA, et al. Trends and outcomes of combined heart-kidney and heart-lung transplantation over the past two decades. J Surg Res, 2024, 295: 574-586.
98.	Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant, 2016, 35(1): 1-23.
99.	Kobashigawa J, Dadhania DM, Farr M, et al. Consensus conference on heart-kidney transplantation. Am J Transplant, 2021, 21(7): 2459-2467.
100.	Ruzza A, Czer LS, Trento A, et al. Combined heart and kidney transplantation: What is the appropriate surgical sequence? Interact Cardiovasc Thorac Surg, 2013, 17(2): 416-418.
101.	Lutz AJ, Nagaraju S, Sharfuddin AA, et al. Simultaneous heart-kidney transplant with planned delayed implantation of the kidney graft after ex vivo perfusion. Transplantation, 2023, 107(9): 2043-2046.
102.	Agarwal KA, Patel H, Agrawal N, et al. Cardiac outcomes in isolated heart and simultaneous kidney and heart transplants in the United States. Kidney Int Rep, 2021, 6(9): 2348-2357.
103.	Brahmbhatt DH, Blitzer D, Billia F, et al. Acute complication posttransplant: Primary allograft dysfunction. Curr Opin Organ Transplant, 2023, 28(5): 376-383.
104.	Kobashigawa J, Zuckermann A, Macdonald P, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant, 2014, 33(4): 327-340.
105.	DePasquale EC, Ardehali A. Primary graft dysfunction in heart transplantation. Curr Opin Organ Transplant, 2018, 23(3): 286-294.
106.	Kolodziej AR, Vaidya GN, Reddy N, et al. Mechanical circulatory support in pre and postheart transplant period. Curr Opin Organ Transplant, 2021, 26(3): 273-281.
107.	Moayedi Y, Truby LK, Foroutan F, et al. The International Consortium on Primary Graft Dysfunction: Redefining clinical risk factors in the contemporary era of heart transplantation. J Card Fail, 2024, 30(6): 805-815.
108.	DeRoo SC, Takayama H, Nemeth S, et al. Extracorporeal membrane oxygenation for primary graft dysfunction after heart transplant. J Thorac Cardiovasc Surg, 2019, 158(6): 1576-1584.
109.	Singh SSA, Dalzell JR, Berry C, et al. Primary graft dysfunction after heart transplantation: A thorn amongst the roses. Heart Fail Rev, 2019, 24(5): 805-820.
110.	Han J, Rushakoff J, Moayedi Y, et al. HLA sensitization is associated with an increased risk of primary graft dysfunction after heart transplantation. J Heart Lung Transplant, 2024, 43(3): 387-393.
111.	Linse B, Ohlsson M, Stehlik J, et al. A machine learning model for prediction of 30-day primary graft failure after heart transplantation. Heliyon, 2023, 9(3): e14282.
112.	Kilic A, Mathier MA, Hickey GW, et al. Evolving trends in adult heart transplant with the 2018 heart allocation policy change. JAMA Cardiol, 2021, 6(2): 159-167.
113.	Zhou AL, Etchill EW, Giuliano KA, et al. Bridge to transplantation from mechanical circulatory support: A narrative review. J Thorac Dis, 2021, 13(12): 6911-6923.
114.	Bernhardt AM, Potapov E, Schibilsky D, et al. First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in Germany. J Heart Lung Transplant, 2021, 40(8): 850-855.
115.	Reich H, Ramzy D, Moriguchi J, et al. Acceptable post-heart transplant outcomes support temporary MCS prioritization in the new OPTN\| UNOS Heart Allocation policy. Transplant Proc, 2021, 53(1): 353-357.
116.	Molina EJ, Shah P, Kiernan MS, et al. The Society of Thoracic Surgeons Intermacs 2020 Annual Report. Ann Thorac Surg, 2021, 111(3): 778-792.
117.	Truby LK, Farr MA, Garan AR, et al. Impact of bridge to transplantation with continuous-flow left ventricular assist devices on posttransplantation Mortality. Circulation, 2019, 140(6): 459-469.
118.	John R, Pagani FD, Naka Y, et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: Impact of duration of left ventricular assist device support and other variables. J Thorac Cardiovasc Surg, 2010, 140(1): 174-181.
119.	Goodwin ML, Kagawa H, Selzman CH. The good, the bad, the ugly: Optimal left ventricular assist device duration in bridge to transplantation. JTCVS Open, 2021, 8: 116-120.
120.	Hulman M, Artemiou P, Ondrusek M, et al. Short-term mechanical circulatory support for severe primary graft dysfunction following orthotopic heart transplant. Interact Cardiovasc Thorac Surg, 2018, 27(2): 229-233.
121.	Ranney DN, Benrashid E, Meza JM, et al. Central cannulation as a viable alternative to peripheral cannulation in extracorporeal membrane oxygenation. Semin Thorac Cardiovasc Surg, 2017, 29(2): 188-195.
122.	Olivella A, Almenar-Bonet L, González-Vilchez F, et al. Mechanical circulatory support in severe primary graft dysfunction: Peripheral cannulation but not earlier implantation improves survival in heart transplantation. J Heart Lung Transplant, 2023, 42(8): 1101-1111.
123.	Lüsebrink E, Binzenhöfer L, Kellnar A, et al. Venting during venoarterial extracorporeal membrane oxygenation. Clin Res Cardiol, 2023, 112(4): 464-505.
124.	Immohr MB, Lichtenberg A, Akhyari P, et al. Multimodal temporary mechanically circulatory assistance for primary graft dysfunction after heart transplantation: A case report. Eur Heart J Case Rep, 2021, 5(12): ytab501.
125.	Iribarne A, Hong KN, Easterwood R, et al. Should heart transplant recipients with early graft failure be considered for retransplantation? Ann Thorac Surg, 2011, 92(3): 923-928.
126.	Chen Q, Malas J, Chan J, et al. Evaluating age-based eligibility thresholds for heart re-transplantation: An analysis of the United Network for Organ Sharing database. J Heart Lung Transplant, 2023, 42(5): 593-602.
127.	Naruka V, Arjomandi Rad A, Subbiah Ponniah H, et al. Machine learning and artificial intelligence in cardiac transplantation: A systematic review. Artif Organs, 2022, 46(9): 1741-1753.
128.	Medved D, Nugues P, Nilsson J. Predicting the outcome for patients in a heart transplantation queue using deep learning. Annu Int Conf IEEE Eng Med Biol Soc, 2017, 2017: 74-77.
129.	Yoon J, Zame WR, Banerjee A, et al. Personalized survival predictions via Trees of Predictors: An application to cardiac transplantation. PLoS One, 2018, 13(3): e0194985.
130.	Kampaktsis PN, Tzani A, Doulamis IP, et al. State-of-the-art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: Results from the UNOS database. Clin Transplant, 2021, 35(8): e14388.
131.	Ayers B, Sandholm T, Gosev I, et al. Using machine learning to improve survival prediction after heart transplantation. J Card Surg, 2021, 36(11): 4113-4120.

1. Martin SS, Aday AW, Almarzooq ZI, et al. 2024 Heart Disease and Stroke Statistics: A report of US and Global Data from the American Heart Association. Circulation, 2024, 149(8): e347-e913.
2. Barnard CN. The operation. A human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J, 1967, 41(48): 1271-1274.
3. Zhu Y, Lingala B, Baiocchi M, et al. The Stanford experience of heart transplantation over five decades. Eur Heart J, 2021, 42(48): 4934-4943.
4. Khush KK, Hsich E, Potena L, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report-2021; Focus on recipient characteristics. J Heart Lung Transplant, 2021, 40(10): 1035-1049.
5. Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report-2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant, 2019, 38(10): 1056-1066.
6. Colvin MM, Smith JM, Ahn YS, et al. OPTN/SRTR 2022 Annual Data Report: Heart. Am J Transplant, 2024, 24(2S1): S305-S393.
7. Jaiswal A, Gadela NV, Baran D, et al. Clinical outcomes of older adults listed for heart transplantation in the United States. J Am Geriatr Soc, 2021, 69(9): 2507-2517.
8. Wever-Pinzon O, Edwards LB, Taylor DO, et al. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management: An analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant, 2017, 36(4): 407-417.
9. Awad MA, Shah A, Griffith BP. Current status and outcomes in heart transplantation: A narrative review. Rev Cardiovasc Med, 2022, 23(1): 11.
10. Schroder JN, Scheuer S, Catarino P, et al. The American Association for Thoracic Surgery 2023 Expert Consensus Document: Adult cardiac transplantation utilizing donors after circulatory death. J Thorac Cardiovasc Surg, 2023, 166(3): 856-869.
11. Chew HC, Iyer A, Connellan M, et al. Outcomes of donation after circulatory death heart transplantation in Australia. J Am Coll Cardiol, 2019, 73(12): 1447-1459.
12. Schroder JN, Patel CB, DeVore AD, et al. Transplantation outcomes with donor hearts after circulatory death. N Engl J Med, 2023, 388(23): 2121-2131.
13. Chen Q, Emerson D, Megna D, et al. Heart transplantation using donation after circulatory death in the United States. J Thorac Cardiovasc Surg, 2023, 165(5): 1849-1860.
14. Urban M, Moody M, Lyden E, et al. Impact of donation after circulatory death heart transplantation on waitlist outcomes and transplantation activity. Clin Transplant, 2023, 37(5): e14942.
15. Smith DE, Kon ZN, Carillo JA, et al. Early experience with donation after circulatory death heart transplantation using normothermic regional perfusion in the United States. J Thorac Cardiovasc Surg, 2022, 164(2): 557-568.
16. Madan S, Saeed O, Forest SJ, et al. Feasibility and potential impact of heart transplantation from adult donors after circulatory death. J Am Coll Cardiol, 2022, 79(2): 148-162.
17. Gernhofer YK, Bui QM, Powell JJ, et al. Heart transplantation from donation after circulatory death: Impact on waitlist time and transplant rate. Am J Transplant, 2023, 23(8): 1241-1255.
18. Hornby L, Dhanani S, Shemie SD. Update of a systematic review of autoresuscitation after cardiac arrest. Crit Care Med, 2018, 46(3): e268-e272.
19. Croome KP, Barbas AS, Whitson B, et al. American Society of Transplant Surgeons recommendations on best practices in donation after circulatory death organ procurement. Am J Transplant, 2023, 23(2): 171-179.
20. Joshi Y, Villanueva J, Gao L, et al. Donation after circulatory death: A new frontier. Curr Cardiol Rep, 2022, 24(12): 1973-1981.
21. Shudo Y, Benjamin-Addy R, Koyano TK, et al. Donors after circulatory death heart trial. Future Cardiol, 2021, 17(1): 11-17.
22. Lerman JB, Agarwal R, Patel CB, et al. Donor heart recovery and preservation modalities in 2024. JACC Heart Fail, 2024, 12(3): 427-437.
23. White CW, Ambrose E, Müller A, et al. Assessment of donor heart viability during ex vivo heart perfusion. Can J Physiol Pharmacol, 2015, 93(10): 893-901.
24. Fedson S. Heart transplant donation after circulatory death: Current status and implications. Curr Opin Cardiol, 2024, 39(2): 128-134.
25. Langmuur SJJ, Amesz JH, Veen KM, et al. Normothermic ex situ heart perfusion with the organ care system for cardiac transplantation: A meta-analysis. Transplantation, 2022, 106(9): 1745-1753.
26. Schroder JN, Patel CB, DeVore AD, et al. Increasing utilization of extended criteria donor hearts for transplantation: The OCS Heart EXPAND Trial. JACC Heart Fail, 2024, 12(3): 438-447.
27. Kothari P. Ex-vivo preservation of heart allografts: An overview of the current state. J Cardiovasc Dev Dis, 2023, 10(3): 105.
28. Urban M, Ryan TR, Um JY, et al. Financial impact of donation after circulatory death heart transplantation: A single-center analysis. Clin Transplant, 2024, 38(4): e15296.
29. Kounatidis D, Brozou V, Anagnostopoulos D, et al. Donor heart preservation: Current knowledge and the new era of machine perfusion. Int J Mol Sci, 2023, 24(23): 16693.
30. Joyce DL, Carlson SF, Kohmoto T, et al. Thoracoabdominal normothermic regional perfusion for cardiac procurement. ASAIO J, 2022, 68(10): e163-e165.
31. Alamouti-Fard E, Garg P, Wadiwala IJ, et al. Normothermic regional perfusion is an emerging cost-effective alternative in donation after circulatory death (DCD) in heart transplantation. Cureus, 2022, 14(6): e26437.
32. Hoffman JRH, McMaster WG, Rali AS, et al. Early US experience with cardiac donation after circulatory death (DCD) using normothermic regional perfusion. J Heart Lung Transplant, 2021, 40(11): 1408-1418.
33. Messer S, Cernic S, Page A, et al. A 5-year single-center early experience of heart transplantation from donation after circulatory-determined death donors. J Heart Lung Transplant, 2020, 39(12): 1463-1475.
34. Entwistle JW, Drake DH, Fenton KN, et al. Normothermic regional perfusion: Ethical issues in thoracic organ donation. Ann Thorac Surg, 2022, 114(1): 44-51.
35. D'Alessandro D, Schroder J, Meyer DM, et al. Impact of controlled hypothermic preservation on outcomes following heart transplantation. J Heart Lung Transplant, 2024, 43(7): 1153-1161.
36. Hendry PJ, Walley VM, Koshal A, et al. Are temperatures attained by donor hearts during transport too cold? J Thorac Cardiovasc Surg, 1989, 98(4): 517-522.
37. Michel SG, LaMuraglia Ii GM, Madariaga ML, et al. Innovative cold storage of donor organs using the Paragonix Sherpa Pak devices. Heart Lung Vessel, 2015, 7(3): 246-255.
38. Copeland H, Hayanga JWA, Neyrinck A, et al. Donor heart and lung procurement: A consensus statement. J Heart Lung Transplant, 2020, 39(6): 501-517.
39. Radakovic D, Karimli S, Penov K, et al. First clinical experience with the novel cold storage SherpaPak™ system for donor heart transportation. J Thorac Dis, 2020, 12(12): 7227-7235.
40. Bitargil M, Haddad O, Pham SM, et al. Packing the donor heart: Is SherpaPak cold preservation technique safer compared to ice cold storage. Clin Transplant, 2022, 36(8): e14707.
41. Zhu Y, Shudo Y, He H, et al. Outcomes of heart transplantation using a temperature-controlled hypothermic storage system. Transplantation, 2023, 107(5): 1151-1157.
42. Shudo Y, Leacche M, Copeland H, et al. A paradigm shift in heart preservation: Improved post-transplant outcomes in recipients of donor hearts preserved with the SherpaPak System. ASAIO J, 2023, 69(11): 993-1000.
43. Voigt JD, Leacche M, Copeland H, et al. Multicenter registry using propensity score analysis to compare a novel transport/preservation system to traditional means on postoperative hospital outcomes and costs for heart transplant patients. ASAIO J, 2023, 69(4): 345-349.
44. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation, 1988, 45(4): 673-676.
45. McGiffin DC, Kure CE, Macdonald PS, et al. Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trial. J Heart Lung Transplant, 2024, 43(3): 485-495.
46. Steen S, Paskevicius A, Liao Q, et al. Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours. Scand Cardiovasc J, 2016, 50(3): 193-200.
47. Nilsson J, Jernryd V, Qin G, et al. A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation. Nat Commun, 2020, 11(1): 2976.
48. Critsinelis AC, Patel S, Nordan T, et al. Trends in outcomes of heart transplants using extended criteria donors: A United Network for Organ Sharing database analysis. Ann Thorac Surg, 2023, 115(6): 1503-1509.
49. Felker GM, Milano CA, Yager JE, et al. Outcomes with an alternate list strategy for heart transplantation. J Heart Lung Transplant, 2005, 24(11): 1781-1786.
50. Weber DJ, Wang IW, Gracon AS, et al. Impact of donor age on survival after heart transplantation: An analysis of the United Network for Organ Sharing (UNOS) registry. J Card Surg, 2014, 29(5): 723-728.
51. Shudo Y, Guenther SP, Lingala B, et al. Relation of length of survival after orthotopic heart transplantation to age of the donor. Am J Cardiol, 2020, 131: 54-59.
52. Lechiancole A, Vendramin I, Sponga S, et al. Influence of donor-transmitted coronary artery disease on long-term outcomes after heart transplantation: A retrospective study. Transpl Int, 2021, 34(2): 281-289.
53. Jahanyar J, Liao JM, Zhang N, et al. Does pre-existing donor heart coronary artery disease impact survival after orthotopic heart transplantation? J Heart Lung Transplant, 2019, 38(4): S185-S186.
54. Sibona A, Khush KK, Oyoyo UE, et al. Long-term transplant outcomes of donor hearts with left ventricular dysfunction. J Thorac Cardiovasc Surg, 2019, 157(5): 1865-1875.
55. Chen CW, Sprys MH, Gaffey AC, et al. Low ejection fraction in donor hearts is not directly associated with increased recipient mortality. J Heart Lung Transplant, 2017, 36(6): 611-615.
56. Wever Pinzon O, Stoddard G, Drakos SG, et al. Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant, 2011, 11(12): 2755-2761.
57. McCulloch MA, Zuckerman WA, Möller T, et al. Effects of donor cause of death, ischemia time, inotrope exposure, troponin values, cardiopulmonary resuscitation, electrocardiographic and echocardiographic data on recipient outcomes: A review of the literature. Pediatr Transplant, 2020, 24(3): e13676.
58. Quader MA, Wolfe LG, Kasirajan V. Heart transplantation outcomes from cardiac arrest-resuscitated donors. J Heart Lung Transplant, 2013, 32(11): 1090-1095.
59. Galeone A, Varnous S, Lebreton G, et al. Impact of cardiac arrest resuscitated donors on heart transplant recipients' outcome. J Thorac Cardiovasc Surg, 2017, 153(3): 622-630.
60. Kulshrestha K, Greenberg JW, Guzman-Gomez AM, et al. Up to an hour of donor resuscitation does not affect pediatric heart transplantation survival. Ann Thorac Surg, 2024, 117(3): 611-618.
61. Leon M, Shudo Y. Optimizing donor heart utilization amidst organ shortage: Feasibility of using hearts post-long CPR. Ann Thorac Surg, 2024, 13: S0003-4975.
62. Copeland H, Knezevic I, Baran DA, et al. Donor heart selection: Evidence-based guidelines for providers. J Heart Lung Transplant, 2023, 42(1): 7-29.
63. Gaffey AC, Doll SL, Thomasson AM, et al. Transplantation of "high-risk" donor hearts: Implications for infection. J Thorac Cardiovasc Surg, 2016, 152(1): 213-220.
64. Gaffey AC, Cucchiara AJ, Goldberg LR, et al. Transplantation of center for disease control "high-risk" donor hearts does not adversely impact long-term outcomes in adults. J Card Fail, 2016, 22(5): 376-382.
65. Gasink LB, Blumberg EA, Localio AR, et al. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients. JAMA, 2006, 296(15): 1843-1850.
66. Aslam S, Grossi P, Schlendorf KH, et al. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. J Heart Lung Transplant, 2020, 39(5): 418-432.
67. Huckaby LV, Seese LM, Handzel R, et al. Center-level utilization of hepatitis C virus-positive donors for orthotopic heart transplantation. Transplantation, 2021, 105(12): 2639-2645.
68. Wang JH, Gustafson SK, Skeans MA, et al. OPTN/SRTR 2018 annual data report: Hepatitis C. Am J Transplant, 2020, 20 Suppl s1: 542-568.
69. Gernhofer YK, Brambatti M, Greenberg BH, et al. The impact of using hepatitis C virus nucleic acid test-positive donor hearts on heart transplant waitlist time and transplant rate. J Heart Lung Transplant, 2019, 38(11): 1178-1188.
70. Mohiuddin MM, Singh AK, Scobie L, et al. Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: A case report. Lancet, 2023, 402(10399): 397-410.
71. Peterson L, Yacoub MH, Ayares D, et al. Physiological basis for xenotransplantation from genetically modified pigs to humans. Physiol Rev, 2024, 104(3): 1409-1459.
72. Schmauch E, Piening B, Mohebnasab M, et al. Integrative multi-omics profiling in human decedents receiving pig heart xenografts. Nat Med, 2024, 30(5): 1448-1460.
73. Krishnan A, Kasinpila P, Wang H, et al. First-in-human beating-heart transplant. JTCVS Tech, 2023, 19: 80-85.
74. Krishnan A, Guenthart BA, Ruaengsri C, et al. Beating heart transplantation: How to do it. Innovations (Phila), 2024, 19(1): 88-91.
75. Krishnan A, Ruaengsri C, Guenthart BA, et al. Beating heart transplant procedures using organs from donors with circulatory death. JAMA Netw Open, 2024, 7(3): e241828.
76. Kothari P, Kiwakyou LM, Guenthart BA, et al. Beating heart transplants-overview and implications for anesthesiologists. J Cardiothorac Vasc Anesth, 2024, 38(3): 610-615.
77. Rajab TK. Partial heart transplantation: Growing heart valve implants for children. Artif Organs, 2024, 48(4): 326-335.
78. Overbey DM, Rajab TK, Turek JW. Partial heart transplantation: How to change the system. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 2024, 27: 100-105.
79. Halder V, Mishra A, Ghosh S, et al. Effectiveness and safety of the Ozaki procedure for aortic valve disease in pediatric patients: A systematic review and meta-analysis. Cureus, 2023, 15(9): e45269.
80. Rajab TK, Vogel AD, Alexander VS, et al. The future of partial heart transplantation. J Heart Lung Transplant, 2024, 43(6): 863-865.
81. Sherard C, Bisbee C, Konsek H, et al. Partial heart transplantation in adult cardiac surgery. Innovations (Phila), 2023, 18(2): 126-131.
82. McGiffin DC, Kirklin JK. The impact of aortic valve homografts on the treatment of aortic prosthetic valve endocarditis. Semin Thorac Cardiovasc Surg. 1995, 7(1): 25-31.
83. Hill MA, Kwon JH, Gerry B, et al. Immune privilege of heart valves. Front Immunol, 2021, 12: 731361.
84. Kwon JH, Hill MA, Gerry B, et al. Cellular viability of partial heart transplant grafts in cold storage. Front Surg, 2021, 8: 676739.
85. Reitz BA. The first successful combined heart-lung transplantation. J Thorac Cardiovasc Surg, 2011, 141(4): 867-869.
86. Shudo Y, Wang H, Lingala B, et al. Evaluation of risk factors for heart-lung transplant recipient outcome: An analysis of the United Network for Organ Sharing database. Circulation, 2019, 140(15): 1261-1272.
87. Elde S, Baccouche BM, Mullis DM, et al. Four decades of progress in heart-lung transplantation: Two hundred seventy-one cases at a single institution. J Thorac Cardiovasc Surg, 2024. [Epub ahead of print].
88. Beal EW, Mumtaz K, Hayes D, et al. Combined heart-liver transplantation: Indications, outcomes and current experience. Transplant Rev (Orlando), 2016, 30(4): 261-268.
89. Emamaullee J, Zaidi AN, Schiano T, et al. Fontan-associated liver disease: Screening, management, and transplant considerations. Circulation, 2020, 142(6): 591-604.
90. Shaw BW, Bahnson HT, Hardesty RL, et al. Combined transplantation of the heart and liver. Ann Surg, 1985, 202(6): 667-672.
91. Lee JTC, Sarode D, Emamaullee JA. Review of pediatric combined heart-liver transplantation: A roadmap to success. Pediatr Transplant, 2023, 27(8): e14633.
92. Elde S, Brubaker AL, Than PA, et al. Operative technique of donor organ procurement for en bloc heart-liver transplantation. Transplantation, 2021, 105(12): 2661-2665.
93. Brozzi NA, Loebe M, Souki FG, et al. En-bloc simultaneous heart-liver transplantation in adult patients. Ann Surg, 2021, 274(6): e1284-e1289.
94. Kobashigawa J, VanWagner LB, Hall S, et al. Summary of a consensus conference on heart-liver transplantation. Am J Transplant, 2024, 24(3): 380-390.
95. Kittleson MM, Sharma K, Brennan DC, et al. Dual-organ transplantation: Indications, evaluation, and outcomes for heart-kidney and heart-liver transplantation: A scientific statement from the American Heart Association. Circulation, 2023, 148(7): 622-636.
96. Rizvi SSA, Challapalli J, Maynes EJ, et al. Indications and outcomes of combined heart-liver transplant: A systematic review and met-analysis. Transplant Rev (Orlando), 2020, 34(2): 100517.
97. Brocklebank P, Shorbaji K, Welch BA, et al. Trends and outcomes of combined heart-kidney and heart-lung transplantation over the past two decades. J Surg Res, 2024, 295: 574-586.
98. Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant, 2016, 35(1): 1-23.
99. Kobashigawa J, Dadhania DM, Farr M, et al. Consensus conference on heart-kidney transplantation. Am J Transplant, 2021, 21(7): 2459-2467.
100. Ruzza A, Czer LS, Trento A, et al. Combined heart and kidney transplantation: What is the appropriate surgical sequence? Interact Cardiovasc Thorac Surg, 2013, 17(2): 416-418.
101. Lutz AJ, Nagaraju S, Sharfuddin AA, et al. Simultaneous heart-kidney transplant with planned delayed implantation of the kidney graft after ex vivo perfusion. Transplantation, 2023, 107(9): 2043-2046.
102. Agarwal KA, Patel H, Agrawal N, et al. Cardiac outcomes in isolated heart and simultaneous kidney and heart transplants in the United States. Kidney Int Rep, 2021, 6(9): 2348-2357.
103. Brahmbhatt DH, Blitzer D, Billia F, et al. Acute complication posttransplant: Primary allograft dysfunction. Curr Opin Organ Transplant, 2023, 28(5): 376-383.
104. Kobashigawa J, Zuckermann A, Macdonald P, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant, 2014, 33(4): 327-340.
105. DePasquale EC, Ardehali A. Primary graft dysfunction in heart transplantation. Curr Opin Organ Transplant, 2018, 23(3): 286-294.
106. Kolodziej AR, Vaidya GN, Reddy N, et al. Mechanical circulatory support in pre and postheart transplant period. Curr Opin Organ Transplant, 2021, 26(3): 273-281.
107. Moayedi Y, Truby LK, Foroutan F, et al. The International Consortium on Primary Graft Dysfunction: Redefining clinical risk factors in the contemporary era of heart transplantation. J Card Fail, 2024, 30(6): 805-815.
108. DeRoo SC, Takayama H, Nemeth S, et al. Extracorporeal membrane oxygenation for primary graft dysfunction after heart transplant. J Thorac Cardiovasc Surg, 2019, 158(6): 1576-1584.
109. Singh SSA, Dalzell JR, Berry C, et al. Primary graft dysfunction after heart transplantation: A thorn amongst the roses. Heart Fail Rev, 2019, 24(5): 805-820.
110. Han J, Rushakoff J, Moayedi Y, et al. HLA sensitization is associated with an increased risk of primary graft dysfunction after heart transplantation. J Heart Lung Transplant, 2024, 43(3): 387-393.
111. Linse B, Ohlsson M, Stehlik J, et al. A machine learning model for prediction of 30-day primary graft failure after heart transplantation. Heliyon, 2023, 9(3): e14282.
112. Kilic A, Mathier MA, Hickey GW, et al. Evolving trends in adult heart transplant with the 2018 heart allocation policy change. JAMA Cardiol, 2021, 6(2): 159-167.
113. Zhou AL, Etchill EW, Giuliano KA, et al. Bridge to transplantation from mechanical circulatory support: A narrative review. J Thorac Dis, 2021, 13(12): 6911-6923.
114. Bernhardt AM, Potapov E, Schibilsky D, et al. First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in Germany. J Heart Lung Transplant, 2021, 40(8): 850-855.
115. Reich H, Ramzy D, Moriguchi J, et al. Acceptable post-heart transplant outcomes support temporary MCS prioritization in the new OPTN| UNOS Heart Allocation policy. Transplant Proc, 2021, 53(1): 353-357.
116. Molina EJ, Shah P, Kiernan MS, et al. The Society of Thoracic Surgeons Intermacs 2020 Annual Report. Ann Thorac Surg, 2021, 111(3): 778-792.
117. Truby LK, Farr MA, Garan AR, et al. Impact of bridge to transplantation with continuous-flow left ventricular assist devices on posttransplantation Mortality. Circulation, 2019, 140(6): 459-469.
118. John R, Pagani FD, Naka Y, et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: Impact of duration of left ventricular assist device support and other variables. J Thorac Cardiovasc Surg, 2010, 140(1): 174-181.
119. Goodwin ML, Kagawa H, Selzman CH. The good, the bad, the ugly: Optimal left ventricular assist device duration in bridge to transplantation. JTCVS Open, 2021, 8: 116-120.
120. Hulman M, Artemiou P, Ondrusek M, et al. Short-term mechanical circulatory support for severe primary graft dysfunction following orthotopic heart transplant. Interact Cardiovasc Thorac Surg, 2018, 27(2): 229-233.
121. Ranney DN, Benrashid E, Meza JM, et al. Central cannulation as a viable alternative to peripheral cannulation in extracorporeal membrane oxygenation. Semin Thorac Cardiovasc Surg, 2017, 29(2): 188-195.
122. Olivella A, Almenar-Bonet L, González-Vilchez F, et al. Mechanical circulatory support in severe primary graft dysfunction: Peripheral cannulation but not earlier implantation improves survival in heart transplantation. J Heart Lung Transplant, 2023, 42(8): 1101-1111.
123. Lüsebrink E, Binzenhöfer L, Kellnar A, et al. Venting during venoarterial extracorporeal membrane oxygenation. Clin Res Cardiol, 2023, 112(4): 464-505.
124. Immohr MB, Lichtenberg A, Akhyari P, et al. Multimodal temporary mechanically circulatory assistance for primary graft dysfunction after heart transplantation: A case report. Eur Heart J Case Rep, 2021, 5(12): ytab501.
125. Iribarne A, Hong KN, Easterwood R, et al. Should heart transplant recipients with early graft failure be considered for retransplantation? Ann Thorac Surg, 2011, 92(3): 923-928.
126. Chen Q, Malas J, Chan J, et al. Evaluating age-based eligibility thresholds for heart re-transplantation: An analysis of the United Network for Organ Sharing database. J Heart Lung Transplant, 2023, 42(5): 593-602.
127. Naruka V, Arjomandi Rad A, Subbiah Ponniah H, et al. Machine learning and artificial intelligence in cardiac transplantation: A systematic review. Artif Organs, 2022, 46(9): 1741-1753.
128. Medved D, Nugues P, Nilsson J. Predicting the outcome for patients in a heart transplantation queue using deep learning. Annu Int Conf IEEE Eng Med Biol Soc, 2017, 2017: 74-77.
129. Yoon J, Zame WR, Banerjee A, et al. Personalized survival predictions via Trees of Predictors: An application to cardiac transplantation. PLoS One, 2018, 13(3): e0194985.
130. Kampaktsis PN, Tzani A, Doulamis IP, et al. State-of-the-art machine learning algorithms for the prediction of outcomes after contemporary heart transplantation: Results from the UNOS database. Clin Transplant, 2021, 35(8): e14388.
131. Ayers B, Sandholm T, Gosev I, et al. Using machine learning to improve survival prediction after heart transplantation. J Card Surg, 2021, 36(11): 4113-4120.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Current status and surgical advances in adult heart transplantation in the United States

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content